Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Core EBITDA Growth

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -23.7618.3121.3829.11-12.99

What is the latest Core EBITDA Growth ratio of CONCORD BIOTECH ?

The latest Core EBITDA Growth ratio of CONCORD BIOTECH is -23.76 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-23.76
Mar202518.31
Mar202421.38
Mar202329.11
Mar2022-12.99

How is Core EBITDA Growth of CONCORD BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2026 -23.76
Negative
Mar2025 18.31
-14.36
Mar2024 21.38
-26.55
Mar2023 29.11
Positive
Mar2022 -12.99 -

Other Financial Ratios of CONCORD BIOTECH


Compare Core EBITDA Growth ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹14,383.0 Cr -5.4% -7.3% -13.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-5.4%

-7.3%

-13.7%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses